Monday, 16 May 2022

 

 

 

Study finds new dual benefit mode of action for drug candidate to fight Covid

Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

London , 15 Jan 2022

A team of researchers has found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2 infections.According to the study, published in the journal Cellular and Molecular Life Sciences, this could constitute the basis for a broadly effective drug to fight Covid-19.The drug can not only inhibit the proliferation of SARS-CoV-2 viruses in cells, but also reduce the exaggerated immune response which represents a serious problem in severe cases of Covid-19."In the results, we have published, we have been able for the first time to show such a dual action for an anti-Covid 19 agent," said researcher Stephan Ludwig from the University of Munster.

The active agent in question, called Zapnometinib or ATR-002, which was originally under development as anti-flu medication, was effective in a variety of cell culture models  including activity against all tested variants of SARS-CoV-2, which also implies broad applicability in facing up to any coming variants in the future.Animal testing to confirm these findings are currently under-way, the team said."Positive results from the still ongoing clinical study in humans might already lead to an emergency approval this year for a new, broadly effective Covid-19 medication. The benefit is clear," said Ludwig.

 

Tags: Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD